Serum creatinine and prostate cancer risk in a prospective study

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 10, 2009, Pages 2643-2649

  Weinstein, Stephanie J ^a   Mackrain, Katrina ^a   Stolzenberg Solomon, Rachael Z ^a   Selhub, Jacob ^b   Virtamo, Jarmo ^c   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER;

AGED; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CREATININE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 70350088262     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0322     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Chiong E, Wong AF, Chan YH, Chin CM. Review of clinical manifestations of biochemically-advanced prostate cancer cases. Asian J Surg 2005;28:202-206 (Pubitemid 41152889)
3. Vesalainen S, Lipponen P, Talja M, Syrjanen K. Biochemical parameters as prognostic factors in prostatic adenocarcinoma. Acta Oncol 1995;34:53-59
4. Fossa SD, Dearnaley DP, Law M, Gad J, Newling DW, Tveter K. Prognostic factors in hormone-resistant progressing cancer of the prostate. Ann Oncol 1992;3:361-366
5. Merseburger AS, Connelly RR, Sun L, Richter E, Moul JW. Use of serum creatinine to predict pathologic stage and recurrence among radical prostatectomy patients. Urology 2001;58:729-734
6. Sandhu DP, Mayor PE, Sambrook PA, George NJ. Outcome and prognostic factors in patients with advanced prostate cancer and obstructive uropathy. Br J Urol 1992;70:412-416
7. Johansson JE, Andersson SO, Holmberg L, Bergstrom R. Prognostic factors in progression-free survival and corrected survival in patients with advanced prostatic cancer: results from a randomized study comprising 150 patients treated with orchiectomy or estrogens. J Urol 1991;146:1327-1332
8. Ribeiro M, Ruff P, Falkson G. Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer. Am J Clin Oncol 1997;20:605-608 (Pubitemid 27509888)
9. Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. Is it time to reevaluate methyl balance in humans? Am J Clin Nutr 2006;83:5-10.
10. Eto I, Krumdieck CL. Role of vitamin B12 and folate deficiencies in carcinogenesis. Adv Exp Med Biol 1986;206:313-330
11. The ATBC Cancer Prevention Study Group. The Alpha-Tocopherol, Beta-Carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994; 4:1-10.
12. Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J. The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol 2002;41:381-388 (Pubitemid 34941123)
13. Pietinen P, Hartman AM, Haapa E, et al. Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 1988;128:655-666
14. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-446 (Pubitemid 28160635)
15. Larsen K. Creatinine assay by a reaction-kinetic principle. Clin Chim Acta 1972;41:209-217
16. Weinstein SJ, Hartman TJ, Stolzenberg-Solomon R, et al. Null association between prostate cancer and serum folate, vitamin B(6), vitamin B(12), and homocysteine. Cancer Epidemiol Biomarkers Prev 2003;12: 1271-1272
17. Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med 1988;39:465-490
18. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992;38: 1933-1953
19. Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2001;161:1207-1216
20. Culleton BF, Larson MG, Evans JC, et al. Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. Arch Intern Med 1999;159:1785-1790
21. Baxmann AC, Ahmed MS, Marques NC, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008;3:348-354
22. Salive ME, Jones CA, Guralnik JM, Agodoa LY, Pahor M, Wallace RB. Serum creatinine levels in older adults: relationship with health status and medications. Age Ageing 1995;24:142-150
23. Vikse BE, Vollset SE, Tell GS, Refsum H, Iversen BM. Distribution and determinants of serum creatinine in the general population: the Hordaland Health Study. Scand J Clin Lab Invest 2004;64:709-722 (Pubitemid 39648132)
24. Schillaci G, Reboldi G, Verdecchia P. High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med 2001;161:886-891 (Pubitemid 32225400)
25. Walsh CR, O'Donnell CJ, Camargo CA, Jr., Giugliano RP, Lloyd-Jones DM. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 2002;144:1003-1011
26. Praught ML, Shlipak MG. Are small changes in serum creatinine an important risk factor? Curr Opin Nephrol Hypertens 2005;14:265-270
27. Jones CA, McQuillan GM, Kusek JW, et al. Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 1998;32:992-999 (Pubitemid 28551162)
28. Ahn JO, Ku JH. Relationship between serum prostate-specific antigen levels and body mass index in healthy younger men. Urology 2006;68: 570-574
29. Ku JH, Kim ME, Lee NK, Park YH, Ahn JO. Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men. Urology 2003; 61:132-136
30. Elshorbagy AK, Oulhaj A, Konstantinova S, et al. Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: use of statistical modeling to determine reference limits. Clin Biochem 2007;40:1209-1218 (Pubitemid 47566421)
31. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001;73:613-621 (Pubitemid 32176514)
32. Calton BA, Chang SC, Wright ME, et al. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control 2007;18:493-503. (Pubitemid 46684823)
33. Eckert RE, Schreier U, Drescher P, et al. Regulation of prostatic smooth muscle contractility by intracellular second messengers: implications for the conservative treatment of benign prostatic hyperplasia. Urol Int 1995;54:6-21.